X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (452564) 452564
Newsletter (34971) 34971
Publication (32432) 32432
Newspaper Article (12320) 12320
Book Review (2449) 2449
Magazine Article (1673) 1673
Book Chapter (877) 877
Conference Proceeding (766) 766
Book / eBook (765) 765
Transcript (444) 444
Web Resource (288) 288
Trade Publication Article (266) 266
Dissertation (234) 234
Streaming Video (76) 76
Reference (68) 68
Government Document (55) 55
Data Set (54) 54
Paper (38) 38
Journal / eJournal (31) 31
Presentation (13) 13
Report (6) 6
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (376074) 376074
female (178279) 178279
index medicus (172326) 172326
male (145304) 145304
oncology (142404) 142404
cancer (134734) 134734
middle aged (111782) 111782
animals (108534) 108534
antineoplastic agents (104751) 104751
antineoplastic agents - therapeutic use (96608) 96608
antimitotic agents (94275) 94275
antineoplastic agents - pharmacology (93567) 93567
aged (92869) 92869
antineoplastic combined chemotherapy protocols - therapeutic use (92335) 92335
adult (90209) 90209
chemotherapy (81584) 81584
care and treatment (65063) 65063
cell line, tumor (62322) 62322
mice (58443) 58443
treatment outcome (56652) 56652
research (55604) 55604
pharmacology & pharmacy (49083) 49083
apoptosis (42587) 42587
neoplasms - drug therapy (39343) 39343
antineoplastic agents - administration & dosage (39198) 39198
antineoplastic agents - adverse effects (36562) 36562
apoptosis - drug effects (33958) 33958
breast neoplasms - drug therapy (33845) 33845
prognosis (32579) 32579
therapy (31151) 31151
dose-response relationship, drug (31018) 31018
drug therapy (31017) 31017
analysis (30968) 30968
health aspects (30968) 30968
antineoplastic agents - chemistry (30618) 30618
combined modality therapy (30388) 30388
antineoplastic combined chemotherapy protocols - adverse effects (28754) 28754
cell proliferation - drug effects (28638) 28638
hematology (28425) 28425
aged, 80 and over (28258) 28258
lung neoplasms - drug therapy (25715) 25715
breast cancer (25473) 25473
oncology, experimental (25468) 25468
biochemistry & molecular biology (25383) 25383
tumors (25190) 25190
expression (24871) 24871
neoplasm staging (23808) 23808
adolescent (23775) 23775
chemistry, medicinal (23220) 23220
cell survival - drug effects (22847) 22847
retrospective studies (22242) 22242
tumor cells, cultured (21453) 21453
time factors (21237) 21237
cisplatin (21172) 21172
drugs (20597) 20597
medicine & public health (20522) 20522
cisplatin - administration & dosage (20499) 20499
disease-free survival (20457) 20457
survival (20265) 20265
metastasis (20184) 20184
drug administration schedule (19790) 19790
drug screening assays, antitumor (19710) 19710
antineoplastic combined chemotherapy protocols - administration & dosage (19468) 19468
carcinoma (19362) 19362
survival rate (19331) 19331
article (18246) 18246
child (18225) 18225
rats (17876) 17876
survival analysis (17669) 17669
doxorubicin - administration & dosage (17638) 17638
drug resistance, neoplasm (17606) 17606
antineoplastic agents, phytogenic - pharmacology (17552) 17552
follow-up studies (17472) 17472
cells (17276) 17276
breast neoplasms - pathology (16828) 16828
fluorouracil - administration & dosage (16677) 16677
reports (16439) 16439
in-vitro (16437) 16437
antineoplastic agents - chemical synthesis (15889) 15889
chemotherapy, adjuvant (15884) 15884
clinical trials as topic (15522) 15522
surgery (15507) 15507
structure-activity relationship (15359) 15359
mice, nude (14994) 14994
cytotoxicity (14380) 14380
hematology, oncology and palliative medicine (14306) 14306
radiotherapy (14252) 14252
cyclophosphamide - administration & dosage (14178) 14178
cell biology (14009) 14009
trial (13718) 13718
molecular structure (13607) 13607
risk factors (13564) 13564
carcinoma, non-small-cell lung - drug therapy (13510) 13510
doxorubicin (13392) 13392
adenocarcinoma - drug therapy (13269) 13269
growth (13173) 13173
breast-cancer (13170) 13170
clinical trials (13027) 13027
xenograft model antitumor assays (13025) 13025
signal transduction - drug effects (13007) 13007
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (382) 382
Online Resources - Online (288) 288
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (51) 51
Collection Dvlpm't (Acquisitions) - Vendor file (43) 43
Collection Dvlpm't (Acquisitions) - Closed Orders (31) 31
Gerstein Science - Periodical Stacks (14) 14
UofT at Mississauga - Stacks (10) 10
Scarborough Hospital - Birchmount (5) 5
Gerstein Science - Bindery (4) 4
Chemistry (A D Allen) - Stacks (3) 3
Lakeridge Health Sciences - Online (3) 3
Scarborough Hospital - Online (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Reference (3) 3
UTL at Downsview - May be requested (3) 3
Credit Valley Hospital - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
Gerstein Science - Reference (2) 2
Scarborough Hospital - General (2) 2
St. Michael's Hospital - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
East Asian (Cheng Yu Tung) - Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Sunnybrook Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Online (1) 1
St. Michael's Hospital - Pharmacy (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Oshawa (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Periodicals (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (469386) 469386
Japanese (16430) 16430
German (6368) 6368
Chinese (6261) 6261
French (5855) 5855
Russian (3952) 3952
Spanish (1226) 1226
Polish (1220) 1220
Italian (1029) 1029
Hungarian (613) 613
Czech (520) 520
Dutch (408) 408
Danish (298) 298
Portuguese (264) 264
Swedish (189) 189
Norwegian (168) 168
Ukrainian (149) 149
Korean (131) 131
Hebrew (128) 128
Finnish (108) 108
Bulgarian (100) 100
Croatian (99) 99
Serbian (93) 93
Slovak (74) 74
Romanian (68) 68
Lithuanian (28) 28
Turkish (23) 23
Bosnian (9) 9
Afrikaans (2) 2
Greek (2) 2
Slovenian (2) 2
Amharic (1) 1
Arabic (1) 1
Icelandic (1) 1
Kurdish (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 08/2013, Volume 53, Issue 8, pp. 866 - 877
Brentuximab vedotin is an antibody–drug conjugate (ADC) that selectively delivers monomethyl auristatin E (MMAE) into CD30‐expressing cells. This study... 
pharmacokinetics | clinical pharmacology | biotechnology | clinical trials | oncology | drug metabolism | Clinical pharmacology | Clinical trials | Drug metabolism | Biotechnology | Oncology | Pharmacokinetics | PHASE-II | ANTITUMOR-ACTIVITY | HODGKINS-DISEASE | LYMPHOMA | PHARMACOLOGY & PHARMACY | SGN-35 | MONOCLONAL-ANTIBODIES | MIDAZOLAM | Ketoconazole - administration & dosage | Humans | Middle Aged | Immunoconjugates - pharmacokinetics | Midazolam - administration & dosage | Ki-1 Antigen - immunology | Male | Antineoplastic Agents - administration & dosage | Immunoconjugates - administration & dosage | Young Adult | Rifampin - adverse effects | Drug Interactions | Midazolam - adverse effects | Antineoplastic Agents - adverse effects | Adult | Female | Antineoplastic Agents - pharmacokinetics | Rifampin - administration & dosage | Hematologic Neoplasms - metabolism | Immunoconjugates - adverse effects | Oligopeptides - metabolism | Midazolam - pharmacokinetics | Cross-Over Studies | Cytochrome P-450 CYP3A Inhibitors | Feces - chemistry | Cytochrome P-450 CYP3A - metabolism | Adolescent | Aged | Ketoconazole - adverse effects | Complications and side effects | Brentuximab vedotin | Drug interactions | Cytochrome P-450 | Physiological aspects | Dosage and administration | Research | Blood diseases | Drug therapy | Clinical Pharmacology | Clinical Trials | Pharmacokinetics and Drug Metabolism
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 12/2014, Volume 24, Issue 23, pp. 5357 - 5363
Journal Article
2005, ISBN 9781588293831, xiv, 382
A fresh examination of the past successes of natural products as medicines and their new future from both conventional and new technologies. High-performance... 
Biological Products | Biological Factors | Pharmacogenetics | Pharmacognosy | therapeutic use | Drug Design | Pharmacy
Book
2008, ISBN 9780123694485, xv, 473 p., [27] p. of plates
The ultimate source of information on the design of new anticancer agents, emphasizing small molecules, this newest work covers recent notable successes... 
Antineoplastic agents | Clinical & internal medicine | Design | Development
Book
Journal Article
Anti-cancer drugs, ISSN 0959-4973, 1990
Journal
Molecular cancer therapeutics, ISSN 1535-7163, 2001
Journal
2008, 1. Aufl., Cancer drug discovery and development series, ISBN 1934115290, xxi, 419
Book
2008, ISBN 9780470723036, xix, 404
Written by the winner of the 2008 Mike Price Fellowship "This volume provides a comprehensive overview of the wealth of information now available in this... 
Chemotherapy | drug therapy | Drug Design | Antineoplastic agents | therapeutic use | Neoplasms | Cancer
Book